EPSTEIN-BARR VIRUS INFECTION
Clinical trials for EPSTEIN-BARR VIRUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new EPSTEIN-BARR VIRUS INFECTION trials appear
Sign up with your email to follow new studies for EPSTEIN-BARR VIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First human trial for new mono and Cancer-Linked virus vaccines
⭐️ VACCINE ⭐️ Recruiting nowThis early-stage study is testing the safety of two new experimental vaccines designed to prevent infection with Epstein-Barr virus (EBV), which causes mono and is linked to certain cancers and autoimmune diseases. The trial will enroll 750 healthy adults aged 18-29, including bo…
Matched conditions: EPSTEIN-BARR VIRUS INFECTION
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 30, 2026 14:30 UTC
-
Custom immune cells target dangerous virus in transplant patients
Disease control Recruiting nowThis early-stage study is testing a new cell therapy for patients who develop an Epstein-Barr virus (EBV) infection after a stem cell transplant. Researchers are using specially engineered immune cells designed to find and attack cells infected with the virus. The main goals are …
Matched conditions: EPSTEIN-BARR VIRUS INFECTION
Phase: PHASE1, PHASE2 • Sponsor: Daihong Liu • Aim: Disease control
Last updated Apr 02, 2026 00:57 UTC